It is with profound sadness that the cell biology community learned of the death of Günter Blobel ([Figure 1](#F1){ref-type="fig"}) on February 18, 2018, unanticipated by most outside his immediate circle. Here I offer a personal reflection of this remarkable scientist, set in the historical dimensions of both his early life and the transformative period of cell biology into which he was "born" and then catalyzed himself so powerfully into its modern era.
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We can always envision "creators" in science but should be cautious in bouncing this term around too loosely. Günter Blobel was a true creator of the modern era of cell biology.

The science that came to be known as cell biology descended from three schools in the early 20th century. One was the rich trove of histology that had arisen from the school of the German pathologist Rudolf Virchow and its important links to the first intimations of disease at the cellular level. Another was the advent of certain dyes, most from the German aniline-based chemical industry. A medical student, Paul Ehrlich, noticed that some dyes differentially stain one cell type versus another and got the idea that this must mean these cells differ in their chemical composition, a truism today and yet a great insight at the time. The third "school" arose from a belief by certain key people that physiology could be understood as the executive functions of cells, even in heterotypic tissues and organs. This idea arose in several quarters but was most effectively articulated by Jacques Loeb. We might note that all of these major developments, the antecedents of cell biology, arose in Germany, where our subject also came into being.

But something was missing. As a graduate student, the histology book assigned to me was the most opaque text I had encountered. This book might have been a premedical curriculum grandee but it was one of the reasons I veered away from that path. What was missing was "life." To divine physiology from static studies of cells and tissues that are pickled and dead is not easy. Loeb and others had mounted a strong program to understand cells as physical chemistry, and this was certainly an epistemological milestone. But that "school" was mainly adopted in areas such as embryonic development and muscle physiology, not the cell itself. Subsequent cell physiologists like Daniel Mazia refined the Loeb momentum, and yet there was a sense that the time had come for new ideas. The 1960s were a time of change in so many dimensions both in American society and in science, and the study of the cell was one to undergo a profound sea change, not unlike the concurrent repositioning of high-energy particle physics and the advent of new ways to dope silicon onto chips. To paraphrase our iconic bard: The times they *were* a-changin'.

Günter Blobel was born in 1936 in a part of Germany then known as Silesia. Like so much of Germany in that era, this region was an epicenter of cultural refinement in literature, art, and philosophy. Günter and his family fled to the West during the war, and on his exit the young boy went through Dresden, recently bombarded by the Americans into near oblivion. We shall return to this.

After completing medical school at Tübingen, the record implies that Günter had turned away from the clinic to biology. He could have pursued this evolving change of interest in Germany but, for whatever reason, he set his sights on America. Van Potter, at the University of Wisconsin, was gaining prominence for trying to connect cancer with what today would be called cell biology. Following a successful PhD there (1967), and with a likely top recommendation from Potter, held in high esteem in the U.S. cell biology and cancer research guild, Günter got a post with George Palade\'s group at Rockefeller University.

At Rockefeller University, two "schools" in physiology had arisen in the 1940s, one focused on looking at cells and tissues as physiology and another, more daring, enterprise that was oriented to homogenates and assessing the biochemical reactions that could be captured in them ([@B2]). But as regards the dawning of the protein traffic concept, a major point to be made as epistemology is that George Palade had become fascinated by this idea based on his own work before Günter Blobel arrived. Palade and Keith Porter at Rockefeller had seen the endoplasmic reticulum and its studded ribosomes and, whereas Porter saw this as structure and likely function, the Palade group saw this motif as a clue to function in the form of actionable experiments. When Günter joined the Palade lab, he soaked into this gestalt. Most of the labs at Rockefeller at this time had a European leader, and the term "gestalt" was not an inaccurate way to describe the motif of the labs. (A few years later, James Darnell, armed with a grant from the Lucille P. Markey Trust, ushered in a new era at Rockefeller that opened the door to more appointments of junior talent to higher ranks---a transformative event that has been a remarkable success.)

The notion that membrane proteins somehow slip into preexisting membranes as a simple Δ*G* and/or Δ*S* event, given the preexisting thermodynamics of that membrane (descended over billions of years of life on Earth), was one of the main features at the cell biology movie house all through the first half of the 20th century. This notion ran on in the bacterial membrane field (to which we shall return), but Keith Porter\'s discovery of the endoplasmic reticulum (ER) gave rise to the idea that maybe there was something more. Membrane proteins might indeed assemble into the ER membrane as a formal constituent, but other proteins were headed elsewhere, namely outside the cell itself. This, of course, is a canon of metazoan life in the Eukarya, and so this ER-based delivery of proteins to the exterior became an epistemological foothold.

In 1975, Günter and his associate Bernhard Dobberstein published two stunning papers in which they showed that an N-terminal sequence targets a nascent polypeptide to the ER. They erected the "signal peptide hypothesis" to capture these findings. As Palade had taught Günter, naming something is very important. In molecular biology, Jacob and Monod were high priests of this art (i.e., the "operon"), but an elegant and eloquent name for something in cell biology was quite new.

And yet, we must always ask whether there is anything new under the sun. In studies of antibody synthesis, César Milstein in Cambridge, England, had observed higher-molecular-weight precursors and speculated that this reflected some kind of tag for either processing or export from the cell. Milstein came to bitterly resent the signal peptide hypothesis Günter and colleagues discovered and even disputed the priority of the idea. In my opinion, he was reaching to a hypothesis from an observation, but his idea was only one of several possibilities. The Blobel and Dobberstien papers had stronger legs as to the hypothesis and was soon followed up by powerful mechanistic discoveries (vide infra). There was also controversy from the bacterial camp around studies of the M13 phage protein by William Wickner. This led to some unpleasantness around the issue of whether the secretion process was protein driven.

The subsequent arrival of Peter Walter and Reid Gilmore in the Blobel lab led to a second and powerfully transformative step. They discovered a machine that propelled the translocation of signal peptide-bearing nascent polypeptides into the ER---the signal recognition particle (SRP) and its receptor in the ER membrane. In subsequent work, Walter and others in the Blobel lab showed that this machine, the signal recognition particle, is an RNA--protein complex that arrests translation after the N-terminal signal peptide is synthesized. On then docking with the ER-located SRP receptor, this translational block is released, now "forcing" the resumed translational elongation to place the nascent polypeptide into an ER channel, later dubbed the "translocon." These discoveries of protein secretion and the machine that accomplishes it are among the greatest exemplifications of biochemistry informing cell biology that either discipline has ever had. These advances later led to unanticipated new findings, such as the unfolded protein response pioneered by Peter Walter. The discovery of the SRP even reached back in cell biology to the ancient nucleolus, which my lab discovered to be the site of SRP assembly, a second function of this organelle, beyond ribosome synthesis.

The Blobel lab later delved into how the nucleus (possibly an ancient endosymbiont of today\'s eukaryotic cells) manages its export and import. This led to major advances in this field, which had been moving a bit sluggishly before. Others had by then discovered nucleus localization signals in certain proteins but the mechanism remained an unresolved problem. Today, the definitive description of nuclear pore complexes has been an accomplishment of the Blobel lab and other disciples there, now that upward promotion at Rockefeller is in play, just as Günter himself was promoted.

Günter Blobel attracted legions of brilliant students and postdocs, as scientists of his charisma always do. He showed them "the ropes" and taught the skills needed to compete in the often tough forum of science, in which he had won wings, while always conveying his passion for wanting them to go on and do well. His trainees have written a powerful remembrance that captures their beloved mentor in perfect ways ([@B1]).

In my nearly 50 years of knowing Günter Blobel, I always saw an open mind and a generous demeanor. He kept his sense of humor close to his chest but on those occasions when it spontaneously broke forth, his hearty laugh almost made the walls rumble. His enthusiasm for discovery was as infectious as that of any scientist I have ever known, and his passionate desire to instill this in the next generation was a signature of his mentorship.

As many know, when Günter received the Nobel Prize (unshared) he donated the almost \$1 million to the restoration of both the cathedral and synagogue in Dresden, whose ruins he saw as a young boy, an image that had never left him. We might reflect on this about our dear friend and colleague. It may say more about him than anything else.

Günter had three American experiences. His first was in the heartland, at the University of Wisconsin, where he benefitted from a talented but understated mentor. His second was at a palatial center of American biomedical science, where he was infused with the extraordinary style and intellect of George Palade. The third was when he became an icon to the legions of students and postdocs who not only worked with him in his exalted lab but also moved to their subsequent stations both in the United States and abroad.

We shall not see the likes of Günter Blobel again any time soon. Our beloved colleague was an immigrant to America and a "Dreamer" before that term came into use. Nothing we can do would honor him more than for us to support their cause in his memory.
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